"Amantadine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antiviral that is used in the prophylactic or symptomatic treatment of influenza A. It is also used as an antiparkinsonian agent, to treat extrapyramidal reactions, and for postherpetic neuralgia. The mechanisms of its effects in movement disorders are not well understood but probably reflect an increase in synthesis and release of dopamine, with perhaps some inhibition of dopamine uptake.
| Descriptor ID |
D000547
|
| MeSH Number(s) |
D02.455.426.100.050.035
|
| Concept/Terms |
Amantadine- Amantadine
- 1-Aminoadamantane
- 1 Aminoadamantane
- Adamantylamine
Amanta-Sulfate-AZU- Amanta-Sulfate-AZU
- Amanta Sulfate AZU
- AmantaSulfateAZU
- Amantadin AZU
- AZU, Amantadin
|
Below are MeSH descriptors whose meaning is more general than "Amantadine".
Below are MeSH descriptors whose meaning is more specific than "Amantadine".
This graph shows the total number of publications written about "Amantadine" by people in this website by year, and whether "Amantadine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 0 | 1 |
| 1999 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2013 | 1 | 0 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amantadine" by people in Profiles.
-
Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double-blind, placebo-controlled multicenter study. Mov Disord. 2017 09; 32(9):1335-1336.
-
Which dyskinesia scale best detects treatment response? Mov Disord. 2013 Mar; 28(3):341-6.
-
Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004. Mov Disord. 2005 May; 20(5):523-39.
-
Parkinson's disease. Clin Neuropharmacol. 1999 Jul-Aug; 22(4):184-91.
-
New lessons from old drugs: amantadine and Parkinson's disease. Neurology. 1998 May; 50(5):1211-2.
-
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity. Pharmacol Biochem Behav. 1990 Feb; 35(2):291-300.
-
Hypersexuality with antiparkinsonian therapy. Clin Neuropharmacol. 1989 Oct; 12(5):375-83.
-
Amantadine and motor fluctuations in chronic Parkinson's disease. Clin Neuropharmacol. 1987 Dec; 10(6):522-6.
-
The pharmacology of olivopontocerebellar atrophy. Adv Neurol. 1984; 41:143-8.
-
Weekly drug holiday in Parkinson disease. Neurology. 1981 Nov; 31(11):1460-2.